MAIA Biotechnology (MAIA) Insider Trading & Ownership $1.52 +0.04 (+2.70%) Closing price 04:10 PM EasternExtended Trading$1.52 -0.01 (-0.33%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock MAIA Biotechnology (NYSEAMERICAN:MAIA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage32.32%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$152.30KNumber OfInsiders Selling(Last 12 Months)0 Get MAIA Insider Trade Alerts Want to know when executives and insiders are buying or selling MAIA Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MAIA Insider Buying and Selling by Quarter MAIA Biotechnology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/3/2025Stan SmithDirectorBuy33,333$1.50$49,999.50 12/13/2024Stan SmithDirectorBuy25,000$1.87$46,750.00 11/1/2024Cristian LuputDirectorBuy22,133$2.51$55,553.83 (Data available from 1/1/2013 forward) MAIA Insider Trading Activity - Frequently Asked Questions Who is on MAIA Biotechnology's Insider Roster? The list of insiders at MAIA Biotechnology includes Cristian Luput, Joseph F Mcguire, Ngar Yee Louie, Ramiro Guerrero, Stan Smith, and Vlad Vitoc. Learn more on insiders at MAIA. What percentage of MAIA Biotechnology stock is owned by insiders? 32.32% of MAIA Biotechnology stock is owned by insiders. Learn more on MAIA's insider holdings. Which MAIA Biotechnology insiders have been buying company stock? The following insiders have purchased MAIA shares in the last 24 months: Cristian Luput ($55,553.83), Ngar Yee Louie ($39,919.95), and Stan Smith ($296,749.30). How much insider buying is happening at MAIA Biotechnology? Insiders have purchased a total of 271,071 MAIA shares in the last 24 months for a total of $392,223.08 bought. MAIA Biotechnology Key ExecutivesDr. Vlad Vitoc M.B.A. (Age 54)M.D., Co-Founder, President, CEO & Chairman of the Board of Directors Compensation: $529.82kMr. Jeffrey C. Himmelreich (Age 49)Head of Finance Compensation: $213.17kDr. Sergei M. Gryaznov Ph.D. (Age 64)Chief Scientific Officer Compensation: $417.33kLinda MoreiraCompany Secretary More Insider Trading Tools from MarketBeat Related Companies VTYX Insider Trades TVGN Insider Trades RAPT Insider Trades CRBU Insider Trades ENGN Insider Trades VYGR Insider Trades CTMX Insider Trades DERM Insider Trades ACRS Insider Trades ENTA Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NYSEAMERICAN:MAIA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredChina's 500 Million Year AdvantageThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MAIA Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MAIA Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
